Recombinant Giardia intestinalis Flap endonuclease 1 (FEN1)

Shipped with Ice Packs
In Stock

Description

FEN1 in Human Biology

Human FEN1 is a well-characterized structure-specific endonuclease critical for DNA replication and repair. Key features include:

  • Function: Cleaves 5' overhanging flaps during Okazaki fragment maturation and long-patch base excision repair .

  • Structure: A 42.5 kDa protein with a conserved XPG/RAD2 endonuclease domain .

  • Interactions: Partners with PCNA, WRN helicase, and APEX1 to resolve stalled replication forks and maintain genome stability .

Table 1: Key Properties of Human FEN1

PropertyDescriptionSource
Molecular Weight42.5 kDa
Substrate Specificity5' flap DNA, DNA bubbles, gaps
Catalytic Activities5'-flap endonuclease, 5'-3' exonuclease, RNase H
Recombinant ProductionExpressed in E. coli with >90% purity; used in SDS-PAGE, MS, and WB

Enzymatic Systems in Giardia intestinalis

  • Deoxyadenosine Kinase (dAK): A unique tetrameric enzyme critical for salvaging deoxyribonucleosides .

  • Thymidine Kinase (TK1-like): High substrate affinity for thymidine, making it a target for antigiardial drugs like azidothymidine .

Notably, no studies on flap endonucleases in Giardia were identified in the search results.

Research Gaps and Challenges

  • Absence of FEN1 Homologs: Current genomic databases (e.g., GiardiaDB) do not annotate a FEN1 homolog in Giardia intestinalis.

  • Salvage Pathway Focus: Giardia’s reliance on salvage enzymes (e.g., dAK, TK1-like) suggests distinct evolutionary adaptations compared to organisms with FEN1 .

  • Technical Barriers: Cloning and characterizing hypothetical nucleases in Giardia require advanced tools like CRISPR/Cas9 or RNAi, which are underdeveloped for this parasite .

Recommendations for Future Studies

  1. Genome Mining: Re-analyze Giardia genomes (e.g., assemblages A, B, E) for potential FEN1-like domains.

  2. Functional Assays: Test recombinant Giardia nucleases for flap cleavage activity using substrates similar to human FEN1.

  3. Drug Development: Explore whether FEN1 inhibitors (e.g., FEN1-targeted anticancer agents) could be repurposed against Giardia if homologs are discovered.

Product Specs

Form
Lyophilized powder. Note: We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery time may vary depending on the purchase method and location. Please consult your local distributors for specific delivery times. Note: All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional charges apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect the contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for reference.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
FEN1; GL50803_16953Flap endonuclease 1; FEN-1; EC 3.1.-.-; Flap structure-specific endonuclease 1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-361
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Giardia intestinalis (strain ATCC 50803 / WB clone C6) (Giardia lamblia)
Target Names
Target Protein Sequence
MGIRGLAKLI EEVAPAAVSK RLIQHYCNKV IAIDASVMLY QFITTITSGD GTALANSSGE VTSHLVGLLA KVIRLAEAGI KPIFVFDGKP PEDKQGELEK RRQAREAAEL EQQKAEEEGN LERAKQLSRR TVKVTQQHCK QAERLLDTLG IPYVVAAGEA EAQCVAMAKE RVCEGVASSD LDVLAFGSPC LIRNLAQGGD REIVEINLNT VLKELGFSYD EFLDLCILCG CDYANSLEGI GPKTAYKLIV KHRSIEEVLA ADQGKLAEKA LNWPYVRARE LFKNPAVIDP KEIKKTLKWK PVNRGEAMQF LVEEMEFDRE TTEKKLDKLV AARKKPKQCT IDSFFSPRSS NPEVTKTKVK Q
Uniprot No.

Target Background

Function
Flap endonuclease 1 (FEN1) is a structure-specific nuclease with 5'-flap endonuclease and 5'-3' exonuclease activities involved in DNA replication and repair. During replication, it cleaves the 5'-overhanging flap created by displacement synthesis when DNA polymerase encounters a downstream Okazaki fragment. It enters the flap from the 5'-end, tracks to the base, and cleaves it, leaving a nick for ligation. FEN1 is also involved in long patch base excision repair (LP-BER) by cleaving within the AP site-terminated flap. It acts as a genome stabilizer, preventing flaps from forming structures that lead to duplications or deletions. It also has 5'-3' exonuclease activity on nicked or gapped double-stranded DNA and exhibits RNase H activity. FEN1 also participates in rDNA replication and repair and mitochondrial DNA repair.
Database Links
Protein Families
XPG/RAD2 endonuclease family, FEN1 subfamily
Subcellular Location
Nucleus, nucleolus. Nucleus, nucleoplasm. Mitochondrion.

Q&A

What is Flap Endonuclease 1 (FEN1) and what is its role in Giardia intestinalis?

FEN1 in Giardia intestinalis is part of the essential DNA replication and repair machinery. This structure-specific nuclease plays critical roles in processing Okazaki fragments during DNA replication and in various DNA repair pathways. In Giardia, FEN1 is particularly important given the unique genomic characteristics of this parasite, including its compact genome and unusual genetic recombination patterns . The enzyme recognizes and cleaves DNA flap structures that occur during DNA replication and repair processes, maintaining genomic integrity in this parasitic organism.

How does Giardia intestinalis culture maintenance affect FEN1 expression studies?

Successful FEN1 expression studies in Giardia require precise culture conditions. Giardia trophozoites are routinely maintained in TYI-S-33 media, with or without nitrogen-sparging depending on the strain adaptation level . For reliable FEN1 expression analysis, cultures should be maintained at 37°C in anaerobic conditions and harvested during logarithmic growth phase to ensure consistent expression levels. Researchers should note that expression patterns may vary between life cycle stages, as the encystation process (which can be triggered using high-bile TYI-S-33 media) leads to significant transcriptional reprogramming . This differential expression should be carefully controlled for when designing experiments focused on FEN1 functional analysis.

How do genetic differences between Giardia assemblages affect FEN1 research?

Research on FEN1 must account for significant genetic variation between Giardia assemblages. Genomic analyses have demonstrated that Giardia intestinalis assemblages show very low frequency of recombination between syntenic core genes, suggesting they represent genetically isolated lineages that could be considered separate species . Draft genomes are available for assemblages A (WB), B (GS), and E (P15), with approximately 5,500 coding gene models identified . When studying FEN1 across assemblages, researchers should consider:

AssemblageHost SpecificityGenetic DivergenceFEN1 Homology Considerations
A (WB)Humans, mammalsReference genomeStandard laboratory model for FEN1 studies
B (GS)Primarily humans~77% nucleotide identity with WBPotential functional variations in FEN1 activity
E (P15)Livestock~81% nucleotide identity with WBEvolutionary adaptations in DNA repair machinery

These genetic differences necessitate careful selection of the appropriate assemblage for your research question and validation of findings across multiple assemblages when possible.

What are the optimal expression systems for producing recombinant Giardia FEN1?

The optimal expression system for recombinant Giardia FEN1 production depends on research objectives. While the search results don't specifically address FEN1 expression systems, we can derive methodological approaches based on general recombinant protein practices and Giardia-specific considerations:

When expressing Giardia proteins in heterologous systems, temperature optimization is critical—reducing expression temperature to 16-18°C often improves solubility of parasite proteins. Additionally, adding 5-10% glycerol to purification buffers typically enhances stability of Giardia proteins during purification processes.

How can researchers effectively design primers for Giardia FEN1 cloning?

Effective primer design for Giardia FEN1 cloning requires specific considerations due to the parasite's unusual genomic features. The following methodological approach is recommended:

  • Reference the appropriate assemblage genome sequence (WB, GS, or P15) from GiardiaDB to ensure targeting the correct strain-specific sequence.

  • Account for Giardia's AT-rich genome composition by designing primers with:

    • Longer lengths (24-30 nucleotides) to ensure specificity

    • GC clamps at the 3' end to improve annealing stability

    • Balanced GC content where possible

  • Include appropriate restriction sites with 4-6 nucleotide overhangs to facilitate directional cloning.

  • Verify primer specificity against the complete Giardia genome to avoid non-specific amplification, particularly important given the compact nature of the Giardia genome.

For complex constructs, employing Gibson Assembly or similar overlap-extension methods often provides superior results compared to traditional restriction-ligation approaches when working with Giardia genes.

What purification protocols yield the highest activity for recombinant Giardia FEN1?

To obtain high-activity recombinant Giardia FEN1, a methodological purification approach should include:

  • Initial capture using immobilized metal affinity chromatography (IMAC) with either Ni-NTA or Co-based resins, with the latter often providing higher purity despite lower yield.

  • Size exclusion chromatography as a secondary purification step to remove aggregates and ensure homogeneous protein preparation.

  • Buffer optimization containing:

    • 20-50 mM Tris-HCl pH 7.5-8.0

    • 100-300 mM NaCl

    • 1-5 mM DTT or 0.5-2 mM TCEP (critical for maintaining cysteine residues in reduced state)

    • 5-10% glycerol for stability

    • 0.5-2 mM MgCl₂ (essential cofactor for FEN1 activity)

  • Activity preservation during storage by flash-freezing aliquots in liquid nitrogen and storing at -80°C with minimal freeze-thaw cycles.

For specialized applications requiring higher purity, ion exchange chromatography using SP-Sepharose at pH 6.5-7.0 provides effective separation from contaminating nucleases that could interfere with activity assays.

How does FEN1 function in Giardia's unusual DNA repair mechanisms?

FEN1's function in Giardia's DNA repair machinery must be understood in the context of this parasite's unique genomic characteristics. Giardia intestinalis exhibits very low frequency of recombination between syntenic core genes , which has significant implications for DNA repair mechanisms.

The research data suggests that Giardia relies heavily on base excision repair (BER) pathways where FEN1 plays a crucial role in long-patch BER. Given the limited homologous recombination in Giardia, the FEN1-dependent BER pathway likely serves as a primary mechanism for maintaining genomic integrity. This contrasts with organisms that can readily utilize homologous recombination for DNA repair.

Methodologically, researchers can investigate FEN1's function in DNA repair by:

  • Developing nuclease assays with damaged DNA substrates specific to different repair pathways

  • Employing DNA damaging agents (like hydrogen peroxide or methyl methanesulfonate) followed by molecular analysis of repair kinetics

  • Using fluorescently labeled DNA substrates to measure repair efficiency in extracts from Giardia with modulated FEN1 expression

What is the relationship between Giardia FEN1 and drug resistance mechanisms?

While specific information on FEN1's role in drug resistance in Giardia is not directly addressed in the search results, we can establish a methodological framework for investigating this relationship based on known drug resistance mechanisms.

The search results indicate that Giardia develops resistance to albendazole (ALB) through multiple mechanisms, including mutations in tubulin genes and broader transcriptomic changes . Similarly, FEN1 may be involved in repair of drug-induced DNA damage or in processing secondary DNA structures that form during stress responses.

To investigate this relationship, researchers should:

  • Compare FEN1 expression levels between drug-susceptible and resistant lines using RT-qPCR and western blotting

  • Assess the impact of FEN1 inhibition on drug sensitivity using:

    • Chemical inhibitors of FEN1 in combination with antigiardial drugs

    • RNAi-based knockdown of FEN1 expression (where applicable)

    • Analysis of downstream repair pathway efficiency

  • Evaluate potential mutations in the FEN1 gene in resistant isolates through:

    • Targeted sequencing of the FEN1 locus

    • Analysis of FEN1 activity in extracts from resistant parasites

A comprehensive analysis of the interactome of drug resistance genes with FEN1 would provide valuable insights into potential functional relationships in resistance mechanisms.

How do transcriptional patterns of FEN1 change during Giardia's life cycle stages?

Understanding FEN1 expression throughout Giardia's life cycle requires careful analysis of stage-specific transcriptomics. While specific FEN1 transcriptional data is not provided in the search results, we can establish methodological approaches based on known transcriptomic studies in Giardia.

Researchers should implement a multi-stage analysis approach:

  • Synchronized culture system:

    • Trophozoites maintained in standard TYI-S-33 media

    • Encystation induced using high-bile modified TYI-S-33 media

    • Excystation protocols using acidic treatment followed by protease exposure

  • Time-course sampling strategy:

    • Collection at specified intervals (0h, 6h, 12h, 24h, 48h) during encystation

    • RNA extraction using protocols optimized for different life stages

    • Strand-specific RNA-sequencing to capture directional transcription

  • Comparative analysis techniques:

    • DESeq2 or edgeR for differential expression analysis

    • Time-series clustering to identify co-regulated genes

    • Correlation with known stage-specific markers

Expected patterns may show increased FEN1 expression during stages with active DNA replication (proliferating trophozoites) and potentially decreased expression during dormant cyst stages with lower metabolic activity.

How do researchers resolve contradictory findings on FEN1 function between different Giardia assemblages?

Resolving contradictory findings between Giardia assemblages requires systematic methodological approaches that account for genetic divergence. The search results highlight that Giardia assemblages represent genetically isolated lineages with very low frequency of recombination between syntenic core genes , which could lead to functional variations in proteins including FEN1.

To methodically resolve contradictions, researchers should:

  • Perform direct comparative analyses using standardized protocols:

    • Express and purify FEN1 from multiple assemblages using identical methods

    • Conduct side-by-side biochemical assays under identical conditions

    • Utilize identical substrate sequences to control for sequence preference variations

  • Account for genetic context effects:

    • Analyze interaction networks through co-immunoprecipitation studies

    • Examine post-translational modifications across assemblages

    • Consider epistatic effects from genetic background differences

  • Validate findings through complementation studies:

    • Express FEN1 from one assemblage in another assemblage background

    • Perform functional rescue experiments in heterologous systems

When contradictions persist, they should be evaluated in light of the evolutionary divergence between assemblages, which the search results suggest should be considered separate species .

What are the most reliable methods for measuring Giardia FEN1 enzymatic activity?

Reliable measurement of Giardia FEN1 enzymatic activity requires carefully designed assays that account for the enzyme's specificity and potential interference factors:

  • Fluorescence-based real-time assays:

    • Employ dual-labeled oligonucleotide substrates with fluorophore-quencher pairs

    • Design flap structures mimicking physiological DNA repair intermediates

    • Monitor reaction kinetics through increased fluorescence upon substrate cleavage

  • Gel-based endpoint assays:

    • Utilize radiolabeled or fluorescently labeled DNA substrates

    • Design a standard substrate panel including:

      • 5' single-flapped DNA

      • 5' double-flapped DNA

      • Nicked DNA duplexes

    • Analyze products using denaturing polyacrylamide gel electrophoresis

  • Activity verification controls:

    • Include metal chelation controls (EDTA) to confirm metal-dependent activity

    • Employ temperature and pH sweeps to determine Giardia-specific optima

    • Compare with recombinant human FEN1 as a benchmark

For quantitative comparisons between different experimental conditions, researchers should use the initial velocity measurements at substrate concentrations below saturation to determine kcat/Km values rather than relying on endpoint measurements.

How does genetic drift impact the interpretation of FEN1 variation in clinical Giardia isolates?

Interpreting FEN1 variation in clinical isolates requires careful consideration of genetic drift effects. The search results indicate that genetic drift, rather than selection, can be a primary determinant of genetic variation in some populations . This has important implications for FEN1 research in Giardia.

Methodological approaches to address drift effects include:

  • Population genomics analysis:

    • Sample multiple isolates from diverse geographical locations

    • Sequence FEN1 loci alongside neutral markers

    • Apply tests of selection (dN/dS ratios, Tajima's D) to distinguish drift from selection

  • Functional impact assessment:

    • Characterize enzymatic properties of variant FEN1 proteins

    • Correlate catalytic parameters with epidemiological data

    • Develop prediction models for functional impact of amino acid substitutions

  • Phylogenetic context evaluation:

    • Compare variation patterns with other DNA repair enzymes

    • Analyze co-evolution with interacting protein partners

    • Construct ancestral sequence reconstructions to identify evolutionary trajectories

For meaningful interpretation, researchers should recognize that "very low frequency of recombination between syntenic core genes" in Giardia can accelerate genetic drift within isolated lineages, potentially leading to functional divergence in enzymes like FEN1 even without selective pressure.

How can CRISPR-based technologies be applied to study FEN1 function in Giardia?

While CRISPR systems are not explicitly discussed in the search results for Giardia, we can outline methodological approaches for applying this technology to FEN1 research:

  • Adaptation of CRISPR system for Giardia:

    • Codon-optimize Cas9/Cas12a for expression in Giardia

    • Design sgRNAs targeting FEN1 locus with high specificity

    • Develop appropriate selection markers for transfected cells

  • Experimental approaches:

    • Generate conditional knockdown systems using inducible promoters

    • Create epitope-tagged versions for localization and interaction studies

    • Introduce specific point mutations to evaluate structure-function relationships

  • Phenotypic analysis:

    • Measure growth defects under normal and stress conditions

    • Assess sensitivity to DNA damaging agents compared to wild-type

    • Quantify genomic instability through mutation frequency analysis

The technical challenges include optimizing transfection efficiency, which typically ranges from 10-20% in Giardia, and developing appropriate selectable markers. Researchers should consider tetracycline-inducible systems when studying essential genes like FEN1, as complete knockout may be lethal.

What approaches can uncover the role of FEN1 in Giardia's unusual genomic stability mechanisms?

Exploring FEN1's role in Giardia's genomic stability requires specialized methodological approaches given the parasite's unique genomic features:

  • Genome-wide stability assessment:

    • Whole genome sequencing of long-term cultures with modulated FEN1 levels

    • Identification of mutational signatures associated with FEN1 deficiency

    • Analysis of microsatellite stability as markers for replication slippage

  • FEN1 interaction network characterization:

    • Proximity-dependent biotin labeling (BioID) to identify interaction partners

    • Co-immunoprecipitation validated by mass spectrometry

    • Yeast two-hybrid screening against Giardia cDNA libraries

  • DNA damage response analysis:

    • Chromatin immunoprecipitation to map FEN1 recruitment to damage sites

    • Live cell imaging using fluorescently tagged FEN1 to track dynamics

    • Correlation with replication timing using DNA combing techniques

These approaches should account for Giardia's "very low frequency of recombination between syntenic core genes" , which suggests alternative mechanisms may compensate for the limited homologous recombination typically used for DNA repair in other organisms.

How can structural biology techniques advance our understanding of Giardia FEN1 specificity?

Advanced structural biology approaches can elucidate the unique aspects of Giardia FEN1 substrate recognition and catalytic mechanism:

  • Comparative structural analysis methodology:

    • X-ray crystallography of Giardia FEN1 with various DNA substrates

    • Cryo-EM studies to capture dynamic conformational states

    • Solution NMR to analyze protein-DNA interactions in real-time

  • Computational approaches:

    • Molecular dynamics simulations to model substrate recognition

    • Quantum mechanics/molecular mechanics calculations to analyze reaction mechanisms

    • Virtual screening for assemblage-specific inhibitors

  • Structure-guided functional analysis:

    • Alanine-scanning mutagenesis of conserved and divergent residues

    • Activity assays with modified substrates to probe binding determinants

    • Thermal shift assays to assess structural stability of variants

The structural insights should be interpreted in the context of Giardia's unusual genome and the potential evolutionary adaptations that may have occurred in its DNA metabolism enzymes. Special attention should be given to comparing structures between different assemblages to identify functional divergence that may have occurred due to limited recombination between these lineages .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.